Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Psychedelics Stock, Up 190% This Year, Flies High Again" is generating significant coverage in the Business category, with 12 articles from 11 distinct sources tracked by PULSE so far.
Outlets currently covering the story include AllSci, TipRanks, Yahoo Finance and Dealroom. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 58d ago.
Quick answers
Why is "Psychedelics Stock, Up 190% This Year, Flies High Again" trending?
Because 11 independent news sources published 12 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (12)
- Definium’s LSD therapy posts second positive Phase III GAD result AllSci · 61d ago
- Definium Therapeutics price target raised to $75 from $70 at Oppenheimer TipRanks · 61d ago
- Definium Reports Second Phase III Success in Anxiety Disorder Program Yahoo Finance · 61d ago
- Definium Therapeutics notches third straight Phase 3 win as DT120 psychedelic hits goals in generalised anxiety disorder Dealroom · 61d ago
- DFTX Maintained by Baird -- Price Target Raised to $79.00 GuruFocus · 61d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder Business Wire · 61d ago
- Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’ BioSpace · 61d ago
- Definium’s LSD therapy eased anxiety in second large trial STAT · 61d ago
- Definium's psychedelic notches another Phase III win in anxiety FirstWord Pharma · 61d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder Yahoo Finance · 61d ago
- Definium's LSD-based anxiety, depression drug scores another trial win Reuters · 61d ago
- Psychedelics Stock, Up 190% This Year, Flies High Again Investor's Business Daily · 61d ago
Topics
Related trends
Marvel star reveals woman was conned into fake relationship with him in ‘disturbing’ AI scam: ‘This is not me’
Ioan Gruffudd says AI-generated explicit images deceived a woman into believing she was in a relationship with the Marvel star.
SpaceX Schedules Starship Test 15. This Is the Cool Part.
SpaceX targets November 13 for Starship Flight 15, aiming to catch both rocket stages for the first time.
Stock futures rise slightly as investors eye AI trade, brace for more data and earnings: Live updates
Stock futures rallied as investors bought the dip following a volatile week, though Nvidia shares dropped premarket.
Bloom Energy Stock Rallies as Barclays Turns Bullish on California Power Partnership
Bloom Energy stock rallies following a strategic California power partnership and a bullish shift by Barclays.
Not IonQ. Not D-Wave. This "Boring" Blue Chip Stock Is Quietly Leading in Quantum Computing
Quantum computing stocks plunged in October as rising rates and dilution fears hammered speculative growth names, with D-Wave down 35.7% and IonQ down 31.7% for the month.
Neurologists Say This Is 1 Of The Best Ways To Protect Your Brain As You Age
Neurologists and health sources outline major risk factors, misconceptions, and everyday habits concerning dementia and Alzheimer's disease.